Table 3.
Treatment and survival outcomes of 8,165 ocular melanoma patients from the SEER database, 1973–2012
| Overall OM | UM | CM | P-value | |
|---|---|---|---|---|
| Frequency, N (%) | 8,165 | 7,516 (92.1) | 649 (7.9) | |
| Treatment, N (%)* | ||||
| Surgery only | 3,769 (47.1) | 3,218 (42.8) | 565 (88.7) | <0.01 |
| Radiation only | 3,192 (39.9) | 3,232 (43) | 6 (0.9) | <0.01 |
| Both | 538 (6.7) | 527 (7) | 15 (2.4) | <0.01 |
| Neither | 504 (6.3) | 539 (7.2) | 51 (8.0) | 0.44 |
| Overall survival in years (mean ± SD) | 14.6±0.2 | 14.6±0.2 | 15.4±0.9 | <0.01 |
| Overall mortality, N (%) | 3,718 (45.5) | 3,466 (46.1) | 252 (38.8) | <0.01 |
| Cancer-specific mortality, N (%) | 1,756 (21.5) | 1,870 (24.9) | 99 (20.0) | <0.01 |
| Cancer-specific relative survival (%) | ||||
| 1 year | 96 | 96 | 95 | 0.25 |
| 2 years | 89 | 89 | 88 | 0.43 |
| 5 years | 71 | 70 | 73 | 0.11 |
Note:
*
Data presented for patients with available data only.
Abbreviations: CM, conjunctival melanoma; N, number; OM, ocular melanoma; SD, standard deviation; SEER, Surveillance, Epidemiology, and End Results; UM, uveal melanoma.